| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |